Abivax Sa American Stock Fundamentals
| ABVX Stock | 7.09 0.25 3.41% |
Abivax SA American fundamentals help investors to digest information that contributes to Abivax SA's financial success or failures. It also enables traders to predict the movement of Abivax Stock. The fundamental analysis module provides a way to measure Abivax SA's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Abivax SA stock.
Abivax |
Abivax SA American Company Shares Outstanding Analysis
Abivax SA's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Abivax SA Shares Outstanding | 62.92 M |
Most of Abivax SA's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Abivax SA American is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Abivax SA American has 62.92 M of shares currently outstending. This is 65.15% lower than that of the Biotechnology sector and 41.12% lower than that of the Health Care industry. The shares outstanding for all United States stocks is 89.0% higher than that of the company.
Abivax SA American Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Abivax SA's current stock value. Our valuation model uses many indicators to compare Abivax SA value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Abivax SA competition to find correlations between indicators driving Abivax SA's intrinsic value. More Info.Abivax SA American is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Abivax SA's earnings, one of the primary drivers of an investment's value.Abivax Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Abivax SA's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Abivax SA could also be used in its relative valuation, which is a method of valuing Abivax SA by comparing valuation metrics of similar companies.Abivax SA is currently under evaluation in shares outstanding category among its peers.
Abivax Fundamentals
| Return On Equity | -1.71 | ||||
| Return On Asset | -0.47 | ||||
| Operating Margin | (11.79) % | ||||
| Current Valuation | 437.7 M | ||||
| Shares Outstanding | 62.92 M | ||||
| Shares Owned By Institutions | 44.66 % | ||||
| Number Of Shares Shorted | 1.15 M | ||||
| Price To Book | 10.58 X | ||||
| Price To Sales | 52.09 X | ||||
| EBITDA | (169.87 M) | ||||
| Net Income | (176.24 M) | ||||
| Total Debt | 97.36 M | ||||
| Book Value Per Share | 2.01 X | ||||
| Cash Flow From Operations | (154.07 M) | ||||
| Short Ratio | 1.14 X | ||||
| Earnings Per Share | (3.66) X | ||||
| Target Price | 35.85 | ||||
| Number Of Employees | 62 | ||||
| Beta | 1.42 | ||||
| Market Capitalization | 649.94 M | ||||
| Total Asset | 205.23 M | ||||
| Retained Earnings | (438.88 M) | ||||
| Working Capital | 77.84 M | ||||
| Net Asset | 205.23 M |
About Abivax SA Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Abivax SA American's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Abivax SA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Abivax SA American based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Abivax Stock Analysis
When running Abivax SA's price analysis, check to measure Abivax SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abivax SA is operating at the current time. Most of Abivax SA's value examination focuses on studying past and present price action to predict the probability of Abivax SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abivax SA's price. Additionally, you may evaluate how the addition of Abivax SA to your portfolios can decrease your overall portfolio volatility.